# Effectiveness and Safety of the Simultaneous Radiotherapy and Hyperthermia After Transarterial Chemoembolization in Hepatocellular Carcinoma Patients Combined With Portal Vein Tumor Thrombosis

> **NCT01911000** · PHASE2 · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 69 (actual)

## Conditions studied

- Carcinoma. Hepatocellular

## Interventions

- **RADIATION:** RT and hyperthermia after TACE

## Key facts

- **NCT ID:** NCT01911000
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2016-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01911000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01911000, "Effectiveness and Safety of the Simultaneous Radiotherapy and Hyperthermia After Transarterial Chemoembolization in Hepatocellular Carcinoma Patients Combined With Portal Vein Tumor Thrombosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01911000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*